Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The FOXP3+ Pro-Inflammatory T Cell: A Potential Therapeutic Target in Crohn's Disease.
Kosinsky RL, Gonzalez MM, Saul D, Barros LL, Sagstetter MR, Fedyshyn Y, Nair A, Sun Z, Hamdan FH, Gibbons HR, Perez Pachon ME, Druliner BR, Johnsen SA, Faubion WA. Kosinsky RL, et al. Among authors: faubion wa. Gastroenterology. 2024 Apr;166(4):631-644.e17. doi: 10.1053/j.gastro.2024.01.007. Epub 2024 Jan 9. Gastroenterology. 2024. PMID: 38211712
EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging.
Faubion WA Jr, Fletcher JG, O'Byrne S, Feagan BG, de Villiers WJ, Salzberg B, Plevy S, Proctor DD, Valentine JF, Higgins PD, Harris JM, Diehl L, Wright L, Tew GW, Luca D, Basu K, Keir ME. Faubion WA Jr, et al. Am J Gastroenterol. 2013 Dec;108(12):1891-900. doi: 10.1038/ajg.2013.354. Epub 2013 Oct 15. Am J Gastroenterol. 2013. PMID: 24126633
Exome sequencing identifies a novel FOXP3 mutation in a 2-generation family with inflammatory bowel disease.
Okou DT, Mondal K, Faubion WA, Kobrynski LJ, Denson LA, Mulle JG, Ramachandran D, Xiong Y, Svingen P, Patel V, Bose P, Waters JP, Prahalad S, Cutler DJ, Zwick ME, Kugathasan S. Okou DT, et al. Among authors: faubion wa. J Pediatr Gastroenterol Nutr. 2014 May;58(5):561-8. doi: 10.1097/MPG.0000000000000302. J Pediatr Gastroenterol Nutr. 2014. PMID: 24792626 Free PMC article.
The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD).
Sarmento OF, Svingen PA, Xiong Y, Sun Z, Bamidele AO, Mathison AJ, Smyrk TC, Nair AA, Gonzalez MM, Sagstetter MR, Baheti S, McGovern DP, Friton JJ, Papadakis KA, Gautam G, Xavier RJ, Urrutia RA, Faubion WA. Sarmento OF, et al. Among authors: faubion wa. J Biol Chem. 2017 Jan 13;292(2):706-722. doi: 10.1074/jbc.M116.749663. Epub 2016 Dec 1. J Biol Chem. 2017. PMID: 27909059 Free PMC article.
Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's Disease.
Dietz AB, Dozois EJ, Fletcher JG, Butler GW, Radel D, Lightner AL, Dave M, Friton J, Nair A, Camilleri ET, Dudakovic A, van Wijnen AJ, Faubion WA. Dietz AB, et al. Among authors: faubion wa. Gastroenterology. 2017 Jul;153(1):59-62.e2. doi: 10.1053/j.gastro.2017.04.001. Epub 2017 Apr 9. Gastroenterology. 2017. PMID: 28400193 Free PMC article. Clinical Trial.
Interdisciplinary Management of Perianal Crohn's Disease.
Lightner AL, Faubion WA, Fletcher JG. Lightner AL, et al. Among authors: faubion wa. Gastroenterol Clin North Am. 2017 Sep;46(3):547-562. doi: 10.1016/j.gtc.2017.05.008. Gastroenterol Clin North Am. 2017. PMID: 28838414 Review.
Targeting Specific Immunologic Pathways in Crohn's Disease.
Ramos GP, Faubion WA, Papadakis KA. Ramos GP, et al. Among authors: faubion wa. Gastroenterol Clin North Am. 2017 Sep;46(3):577-588. doi: 10.1016/j.gtc.2017.05.009. Epub 2017 Jul 19. Gastroenterol Clin North Am. 2017. PMID: 28838416 Review.
175 results